BMRA - バイオメリカ (Biomerica Inc.) バイオメリカ

 BMRAのチャート


 BMRAの企業情報

symbol BMRA
会社名 Biomerica Inc (バイオメリカ)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 Biomerica Inc. is a biomedical company which develops manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company''s medical diagnostic products are sold around the world in over two markets including clinical laboratories and point of care (physicians'' offices and over-the-counter drugstores). The Company operates in Europe the United States Asia South America the Middle East and other foreign countries. The Company''s diagnostic test kits are used to analyze blood urine or fecal specimens from patients in the diagnosis of various diseases and other medical complications or to measure the level of specific hormones antibodies antigens or other substances which exist in the human body in various concentrations. The Company primarily focuses on products for gastrointestinal (GI) food intolerances diabetes and esoteric tests. The Company''s diagnostic products use immunoassay technology.   バイオメリカは米国の医療診断製品メ―カ―。病気の早期発見と慢性疾患のモニタリングのために血液、尿、便、ホルモン、抗原体などを測定するテスト・キットを開発・製造する。主に、糖尿病、胃腸疾患、食物不耐症などの診断やモニタリングに使用される。同社製品は酵素免疫測定技術に基づく。本社はカリフォルニア州ア―バイン。   Biomerica, Inc. is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica primarily focuses on products for Gastrointestinal Disease, Diabetes and esoteric testing.
本社所在地 17571 Von Karman Avenue Irvine CA 92614 USA
代表者氏名 Zackary S. Irani ザッカーリS.イラン
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 949-645-2111
設立年月日 26177
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 39人
url www.biomerica.com
nasdaq_url https://www.nasdaq.com/symbol/bmra
adr_tso
EBITDA EBITDA(百万ドル) -1.29514
終値(lastsale) 3.54
時価総額(marketcap) 30627941.94
時価総額 時価総額(百万ドル) 31.65588
売上高 売上高(百万ドル) 5.56419
企業価値(EV) 企業価値(EV)(百万ドル) 30.45098
当期純利益 当期純利益(百万ドル) -1.46583
決算概要 決算概要 BRIEF: For the fiscal year ended 31 May 2018 Biomerica Inc. revenues decreased 4% to $5.6M. Net loss increased 61% to $1.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development increase of 24% to $1.4M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.11 to -$0.17.

 BMRAのテクニカル分析


 BMRAのニュース

   Biomerica inks exclusive distribution agreement in Canada for Helicobacter pylori test  2021/06/24 12:30:08 Seeking Alpha
   Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect  2021/06/24 12:19:00 Wallstreet:Online
Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the population IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomericas new and proprietary Helicobacter pylori test, called hp+detect.
   Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect  2021/06/24 12:19:00 Intrado Digital Media
IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomericas new and proprietary Helicobacter pylori test, called hp+detect. The hp+detect product has been developed for the identification and monitoring of H. pylori infection, the leading cause of duodenal and gastric ulcers, and a contributing risk factor associated with gastric cancer. Physicians and medical centers can use hp+detect to diagnose the presence of H. pylori and to monitor the efficacy of treatment.
   Biomerica gets notice of allowance from Mexican Patent Office  2021/06/15 12:45:37 Seeking Alpha
   Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment  2021/06/15 12:19:00 Intrado Digital Media
IRVINE, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA ) today announced that the Mexican Patent Office has issued a notice of allowance for Biomericas patent application pertaining to the Companys InFoods ® technology platform that offers a revolutionary approach in the treatment of patients suffering from Irritable Bowel Syndrome (IBS). Specifically, this allowed application contains claims that broadly cover the method that enables physicians to identify patient specific foods, such as milk, shrimp, broccoli, etc., that, when removed from the patients diet, may alleviate or improve an individuals IBS symptoms, including constipation, diarrhea, bloating, severe cramping, pain and indigestion.
   Biomerica inks exclusive distribution agreement in Canada for Helicobacter pylori test  2021/06/24 12:30:08 Seeking Alpha
   Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect  2021/06/24 12:19:00 Wallstreet:Online
Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the population IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomericas new and proprietary Helicobacter pylori test, called hp+detect.
   Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect  2021/06/24 12:19:00 Intrado Digital Media
IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomericas new and proprietary Helicobacter pylori test, called hp+detect. The hp+detect product has been developed for the identification and monitoring of H. pylori infection, the leading cause of duodenal and gastric ulcers, and a contributing risk factor associated with gastric cancer. Physicians and medical centers can use hp+detect to diagnose the presence of H. pylori and to monitor the efficacy of treatment.
   Biomerica gets notice of allowance from Mexican Patent Office  2021/06/15 12:45:37 Seeking Alpha
   Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment  2021/06/15 12:19:00 Intrado Digital Media
IRVINE, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA ) today announced that the Mexican Patent Office has issued a notice of allowance for Biomericas patent application pertaining to the Companys InFoods ® technology platform that offers a revolutionary approach in the treatment of patients suffering from Irritable Bowel Syndrome (IBS). Specifically, this allowed application contains claims that broadly cover the method that enables physicians to identify patient specific foods, such as milk, shrimp, broccoli, etc., that, when removed from the patients diet, may alleviate or improve an individuals IBS symptoms, including constipation, diarrhea, bloating, severe cramping, pain and indigestion.
   Rapid Cancer Tests Market 2020 Precise Outlook – Abingdon Health, Hologic, Abbott, NanoEntek, Biomerica, Alfa Scientific Designs, Exact Sciences, Biosynex  2020/11/03 08:10:09 OpenPR
The Rapid Cancer Tests Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic
   Mid-Day Market Update: Biomerica Drops After Q1 Results; CIT Group Shares Surge  2020/10/16 12:04:00 Benzinga
Midway through trading Friday, the Dow traded up 0.83% to 28730.49 while the NASDAQ rose 0.23% to 11740.59. The S&P also rose, gaining 0.49% to …
   A new study evaluated the accuracy of more than 60 coronavirus antibody tests. 13 were a cut above the rest.  2020/07/23 11:47:00 Business Insider
A new review ranked the top 13 coronavirus antibody tests out of more than 60 on the market. The best tests had very few instances of false positive or false negative results. But other tests had a wide range of accuracy levels, and some were less accurate than their manufacturers claimed. Visit Business Insider's homepage for more stories . Hopes were high when the first coronavirus antibody tests debuted a few months ago. There was talk of issuing immunity passports based on the results. The tests were so coveted in the US that the Food and Drug Administration allowed some to go straight to market. Antibody tests detect our body's natural defense against a foreign pathogen. That means they can tell whether someone has ever been infected with COVID-19 — even if that person wasn't able to get tested initially. They can also give researchers a picture of how much the virus has spread within a population. But more than three months later, research shows many antibody tests don't offer consistently reliable results, and some are far more accurate than others .
   Biomerica : UTH Joins InFoods Clinical Trial -- June 29,2020 | MarketScreener  2020/06/30 16:44:10 MarketScreener
The University of Texas Health Science Center at Houston joins Biomerica's InFoods� Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial Click link above… | June 30, 2020

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 バイオメリカ BMRA Biomerica Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)